Kymera Therapeutics Inc Financial Flexibility Index
Kymera Therapeutics Inc financial flexibility index. Kymera Therapeutics Inc (KYMR) has a Financial Flexibility Index of -0.38x as of June 2026. Free cash flow of $-53.59 Million (operating CF $-54.06 Million minus capex $473.00K) represents 0% of total liabilities ($139.85 Million). See KYMR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kymera Therapeutics Inc (2018–2025)
Financial flexibility index of Kymera Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Kymera Therapeutics Inc across 8 annual periods. Explore cash flow to debt ratio of Kymera Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Kymera Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Kymera Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Kymera Therapeutics Inc. For the full cash flow conversion analysis, see KYMR cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.42x | $-231.44 Million | $-232.89 Million | $163.15 Million | ▼ -11.2% |
| 2024 | -1.28x | $-181.66 Million | $-194.50 Million | $142.42 Million | ▼ -237.4% |
| 2023 | -0.38x | $-68.35 Million | $-102.83 Million | $180.79 Million | ▲ +71.6% |
| 2022 | -1.33x | $-150.25 Million | $-153.09 Million | $112.98 Million | ▼ -52.7% |
| 2021 | -0.87x | $-127.35 Million | $-128.95 Million | $146.27 Million | ▼ -282.0% |
| 2020 | 0.48x | $97.23 Million | $88.13 Million | $203.29 Million | ▲ +395.7% |
| 2019 | 0.10x | $18.44 Million | $17.91 Million | $191.11 Million | ▲ +146.0% |
| 2018 | -0.21x | $-16.51 Million | $-17.86 Million | $78.67 Million | — |